NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 11 04:00PM ET
2.81
Dollar change
-0.05
Percentage change
-1.75
%
Index- P/E- EPS (ttm)- Insider Own34.36% Shs Outstand33.94M Perf Week1.08%
Market Cap105.15M Forward P/E- EPS next Y-0.17 Insider Trans0.00% Shs Float24.57M Perf Month35.75%
Enterprise Value104.16M PEG- EPS next Q-0.05 Inst Own5.57% Short Float0.51% Perf Quarter155.45%
Income- P/S- EPS this Y57.50% Inst Trans129.16% Short Ratio0.79 Perf Half Y140.29%
Sales- P/B- EPS next Y0.00% ROA- Short Interest0.13M Perf YTD144.37%
Book/sh-0.21 P/C106.21 EPS next 5Y- ROE- 52W High3.11 -9.65% Perf Year136.13%
Cash/sh0.03 P/FCF- EPS past 3/5Y-385.84% -126.59% ROIC- 52W Low0.81 247.99% Perf 3Y33.81%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility6.31% 11.75% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)0.22 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.28 Sales Y/Y TTM- Profit Margin- RSI (14)61.97 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.28 EPS Q/Q-2855.56% SMA208.21% Beta-0.09 Target Price7.00
Payout- Debt/Eq- Sales Q/Q- SMA5036.81% Rel Volume0.52 Prev Close2.86
Employees- LT Debt/Eq- Earnings- SMA200105.10% Avg Volume158.32K Price2.81
IPOMay 17, 2022 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume81,852 Change-1.75%
Jun-11-25 10:05AM
08:30AM
May-19-25 07:00AM
May-01-25 07:00AM
Apr-30-25 07:00AM
08:00AM Loading…
Mar-31-25 08:00AM
Mar-10-25 08:30AM
Feb-12-25 07:00AM
Jan-31-25 07:00AM
Jan-30-25 09:45AM
Jan-29-25 08:00AM
Jan-23-25 07:11AM
Jan-22-25 07:00AM
Nov-26-24 07:00AM
Nov-15-24 09:00AM
07:00AM Loading…
Oct-30-24 07:00AM
Oct-23-24 07:00AM
Oct-17-24 07:27AM
Oct-16-24 07:00AM
Sep-10-24 07:00AM
Sep-05-24 07:00AM
Aug-27-24 07:00AM
Aug-23-24 09:00AM
09:00AM
07:00AM
Aug-21-24 07:00AM
Aug-15-24 12:13PM
Aug-06-24 07:00AM
Jul-11-24 07:00AM
Jul-10-24 07:00AM
10:29AM Loading…
Jun-26-24 10:29AM
May-24-24 03:07PM
May-08-24 07:00AM
Apr-30-24 07:00AM
Apr-08-24 07:00PM
Apr-02-24 07:00AM
Mar-22-24 07:00AM
Mar-21-24 07:00AM
Mar-20-24 07:00AM
Feb-09-24 07:00AM
Jan-31-24 07:00AM
Jan-08-24 07:00AM
Jan-05-24 09:30AM
Dec-04-23 07:00AM
Oct-31-23 07:00AM
Oct-09-23 07:00AM
Oct-05-23 07:00AM
Sep-15-23 07:00AM
Sep-14-23 09:15AM
08:45AM
Sep-13-23 04:05PM
Sep-08-23 07:00AM
Aug-30-23 07:00AM
Aug-29-23 07:00AM
Aug-15-23 09:00AM
Jul-31-23 02:18AM
Jul-28-23 05:25PM
05:05PM
07:01AM
Jul-27-23 11:30AM
Jun-06-23 09:30AM
May-11-23 07:00AM
May-09-23 08:45AM
May-04-23 01:22PM
May-03-23 02:00AM
May-02-23 02:00AM
Apr-25-23 02:00AM
Apr-18-23 10:00AM
OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK geographical segments. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.